Exposing the Cracks at the Heart of Putin's War Economy
The Big Take
The Russian economy is spluttering under the weight of Moscow's invasion of Ukraine just as Presidents Putin and Trump meet to talk peace
Growth in the Russian economy is stalling. Oil revenues have slumped. The budget deficit has widened to the largest in more than three decades. Inflation and interest rates remain painfully high. Behind the walls of the country's banks, some insiders are sounding alarms about a looming debt crisis.
That's the tense backdrop against which Russian President Vladimir Putin — who has sought to turn the country's financial system into a war machine — travels to Alaska for Friday's summit with his US counterpart Donald Trump. The two will discuss a settlement of the Ukraine conflict, begun by Putin in February 2022, but Trump has already chided his guest this week saying he should concentrate on repairing the Russian economy which 'is not doing well right now.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Carlsmed's Personalized Spine Implants Get Significant Reimbursement Advantage
Carlsmed Inc. (NASDAQ:CARL), an AI-powered innovator in spine surgery, is poised for significant growth following key advancements and strong analyst projections. The company recently secured additional Medicare reimbursement for its aprevo personalized interbody implants for cervical fusion procedures, effective October 1, enhancing its financial outlook. This favorable reimbursement, granted through the Centers for Medicare & Medicaid Services' (CMS) New Technology Add-On Payment (NTAP) program in the Hospital Inpatient Prospective Payment Systems (IPPS) Final Rule for fiscal year 2026, means cervical fusion procedures using aprevo devices will be eligible for an additional $21,125 beyond standard Medicare Severity-Diagnosis-Related Groups (MS-DRGs) for qualifying inpatient benefit extends to private payors as well, utilizing unique ICD-10-PCS procedure codes. Carlsmed, which priced its initial public offering of 6.7 million shares at $15 per share in July, focuses on AI-enabled personalized spine surgery solutions. Its aprevo cervical system, having received FDA Breakthrough Device designation, is anticipated for a U.S. commercial launch in of America Securities (BofA) has initiated coverage on Carlsmed with a Buy rating and a price forecast of $16, recognizing the company's potential to establish a new standard of care in spine fusion. BofA analyst Travis Steed highlighted Carlsmed's differentiated technology and robust outlook, assigning a premium valuation of 5x 2026 estimated revenue. This premium, higher than recent medtech IPOs and other spine companies, is justified by Carlsmed's projected high revenue growth and strong gross margin profile. BofA conservatively forecasts Carlsmed will add around 20-25 new surgeons each quarter through 2027, indicating a steady increase in adoption. Carlsmed forecasts impressive top-line growth: 66% in 2025 and an annual 40-45% through 2028. Its asset-light business model is expected to support profitability, with gross margins in the mid-70s and capital expenditures at just 1% of sales, significantly lower than the approximately 10% for traditional spine peers. BofA estimates the total spine market at roughly $1.4 billion, with a compound annual growth rate (CAGR) of approximately 1.5%. In the first quarter of 2025, the global spine market (including biologics) saw 2.6% organic growth, driven by a 4.1% increase in the U.S. market. Despite the market being largely commoditized and dominated by major players like Medtronic Plc (NYSE:MDT), Globus Medical Inc (NYSE:GMED), Alphatec Holdings Inc. (NASDAQ:ATEC), Johnson and Johnson (NYSE:JNJ), and Orthofix Medical Inc. (NYSE:OFIX) (who collectively hold about 70% of the market), spine surgeons notably favor new technology. The remaining 30% of the market is split among many smaller companies, creating an opportunity for new market entrants with disruptive technology like Carlsmed's to gain traction. BofA sees significant market share capture potential for Carlsmed, with analyst Steed estimating total revenue of $133 million in 2028, representing only about 1% of the total U.S. spine market. Price Action: CARL stock is trading higher by 0.88% to $13.70 at last check Monday. Read Next:Photo via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? This article Carlsmed's Personalized Spine Implants Get Significant Reimbursement Advantage originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio
Yahoo
27 minutes ago
- Yahoo
Trump vows to end mail-in ballots with executive order
Former President Donald Trump said Monday that he plans to sign an executive order aimed at ending mail-in voting and eliminating voting machines, a proposal that election experts note he cannot carry out on his own. Trump has long criticized mail-in ballots, calling them fraudulent. On his Truth Social account, Trump wrote: 'THE MAIL-IN BALLOT HOAX, USING VOTING MACHINES THAT ARE A COMPLETE AND TOTAL DISASTER, MUST END, NOW!!!' He also said his order would 'help bring HONESTY to the 2026 Midterm Elections.' According to the New York Times, the Constitution gives states the authority to set the 'times, places and manner' of elections, with Congress able to override state rules. That means Trump could not unilaterally end mail-in voting or require states to stop using voting machines, even if he returns to office. KIRO 7 News has reached out to the office of Gov. Ferguson for comment. California Governor Gavin Newsom responded to Trump, saying on X, 'His plan to rig new Congressional seats is going to backfire — thanks to he's clamoring for other ways to cook the results." Trump claimed in his post that states serve as 'merely an agent' for the federal government in counting ballots and that they must follow the president's instructions. Legal scholars say this interpretation is at odds with constitutional law and decades of precedent. He also repeated an inaccurate assertion that the United States is the 'only Country in the World that uses Mail-In Voting.' In reality, many democracies, including Canada, Germany, and the United Kingdom, allow citizens to vote by mail under certain conditions. Trump's position comes despite evidence that Republicans made gains in mail-in voting during the 2024 elections after the party encouraged supporters to use it. In past elections, skepticism toward the practice had sometimes disadvantaged GOP candidates, as Democrats more often embraced early and absentee ballots. In his Truth Social post, Trump argued that Democrats are 'virtually Unelectable' without mail-in voting. He also said that electronic voting machines are inaccurate and expensive. His remarks followed a recent summit with Russian President Vladimir V. Putin in Alaska. Trump told Fox News that Putin agreed with him that the 2020 election was 'rigged' because of mail-in ballots, quoting Putin as saying, 'Your election was rigged because you have mail-in voting.' It remains unclear what language Trump's proposed executive order would contain or how he would attempt to enforce it, given that election administration is largely managed at the state level.
Yahoo
27 minutes ago
- Yahoo
Clean energy investors relieved by Trump tax rule changes
(Reuters) -Shares of U.S. solar energy companies rose on Monday after the Trump administration released new subsidy rules for clean energy projects that were not as stringent as many investors had feared. Late on Friday, the Treasury Department narrowed the definition for what it means for a solar or wind project to be considered under construction, a requirement to qualify for federal tax credits worth 30% of a project's cost. The changes include requiring developers of big solar arrays and wind farms to complete physical work rather than simply show that they have invested capital. Solar companies criticized the move on Friday, but analysts, investors and others said the guidelines were better than many expected. The MAC Global Solar Energy index was up 4% in mid-day trade, with top gainers, including residential solar company Sunrun, up 9%, and panel manufacturer First Solar, up 8.6%. "Although it creates some complications, it is manageable," Raymond James analyst Pavel Molchanov said in an email. Some in the industry had feared that project developers would have to incur a large percentage of project costs in order to be eligible for the credits, or that they would have a narrower timeline to claim the subsidies after starting construction. The Treasury Department left the 4-year window unchanged for projects that start construction before the credits expire. The One Big Beautiful Bill Act requires projects to begin construction by July of next year or enter service by the end of 2027 to qualify for a 30% tax credit and bonuses that can push the subsidy even higher. Under previous law, the credits were available through 2032. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
